Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2007
03/08/2007WO2005115547A3 Myricitrin compounds for sleeping disorders
03/08/2007WO2003094835A3 Fgf variants and methods for use thereof
03/08/2007WO2003047611A8 Ptp10d, tec and edtp involved in triglycerid-metabolism
03/08/2007WO2003020702A3 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/08/2007US20070055459 Structure-based approach to design of protein-processivity factor interactions
03/08/2007US20070055054 Homogeneous preparations of il-28 and il-29
03/08/2007US20070055053 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing
03/08/2007US20070055052 Homogeneous preparations of il-28 and il-29
03/08/2007US20070055051 A polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity
03/08/2007US20070055050 Methods and reagents for diagnosis and treatment of diabetes
03/08/2007US20070054962 Method for treating acute or chronic pain
03/08/2007US20070054961 Factor
03/08/2007US20070054869 Antisense modulation of superoxide dismutase 1, soluble expression
03/08/2007US20070054866 Arginyl-glutamine dipeptide for treatment of pathological vascular proliferation
03/08/2007US20070054865 Dipeptides and tripeptides for treating inflammatory reactions, including allergic reactions associated with asthma, rhinitis, conjunctivitis, atopic dermatitis and intestinal anaphylaxis; cyclohexylalanine-L-glutamic acid-glycine
03/08/2007US20070054864 1-[2S-(3-Tert-butylureido)-3,3-dimethylbutyryl]-4R-(7-methoxy-2-pyrazol-1-yl-quinolin-4-yloxy)-pyrrolidine-2S-carboxylic acid (1S-cyclopropylaminooxalylbutyl)amide, for example; useful in treating hepatitis C infections
03/08/2007US20070054863 modulators of Bcl-2 genes and proteins, comprising a mixture of a pro-apoptotic peptide and a cell-penetrating-peptide, that induces apoptosis of mammalian cells expressing Bcl-2 genes or Bcl-2 related proteins, used for for treatment of proliferative diseases and neurodegenerative diseases
03/08/2007US20070054862 Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing an Adenosine Kinase
03/08/2007US20070054861 Therapeutic uses of SMR1 peptides
03/08/2007US20070054860 Use of human chorionic gonadotropin (hCG)-derived peptides; reperfusion injuries; NF-kappa B-down-regulating peptide
03/08/2007US20070054859 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation
03/08/2007US20070054858 Method of treating hepatocellular carcinoma
03/08/2007US20070054857 Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof
03/08/2007US20070054856 Compositions and methods of using angiopoietin-like 4 protein
03/08/2007US20070054855 Annexin V is used to prevent thrombosis without increasing hemorrhage; annexin binds to phosphatidylserine on outer surface of cell membranes, thereby preventing binding of prothrombinase complex necessary for thrombus formation
03/08/2007US20070054854 Methods of using retro-inverso peptides derived from interleukin-3
03/08/2007US20070054853 Composition and Method for Treatment and Prevention of Restenosis
03/08/2007US20070054852 Compositions and methods of use of Semaphorin 3F and antagonists thereof in the stimulation of neuromuscular regeneration and treatment of muscular diseases
03/08/2007US20070054851 Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases
03/08/2007US20070054850 Screening method
03/08/2007US20070054849 Method for diagnosing hepatocellular carcinomas
03/08/2007US20070054848 Composition and method for nerve regeneration
03/08/2007US20070054847 Use of adnf polypeptides for treating anxiety and depression
03/08/2007US20070054846 Bcl-w structure and uses therefor
03/08/2007US20070054845 Which block binding of polypeptides; treatment of metabolic disorders such as obesity, hyperlipidemias, atherosclerosis, diabetes, and hypertension
03/08/2007US20070054844 topically administering to a otitis externa patient an antifungal agent such as fluconazole, voriconazole, itraconazole, clotrimazole and amphotericin B, and an antibacterial agent such as neomycin sulfate, polymyxin B sulfate with an excipient
03/08/2007US20070054843 Methods for treatment of headaches by administration of oxytocin
03/08/2007US20070054842 treating hepatitis by modulating NS3/NS4 protease comprising contacting a NS3/NS4 protease with a compound of the invention
03/08/2007US20070054841 Method of treatment of systemic injury secondary to burns
03/08/2007US20070054840 Template-fixed peptidomimetics with antimicrobial activity
03/08/2007US20070054839 Method of inhibiting remnant lipoprotein production
03/08/2007US20070054377 Homogeneous preparations of il-28 and il-29
03/08/2007US20070054376 Produced by mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins; has anti-hepatitis activity; culturing
03/08/2007US20070054375 Mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity
03/08/2007US20070054374 Homogeneous preparations of il-28 and il-29
03/08/2007US20070054366 Fvii or fviia variants
03/08/2007US20070054364 Polypeptide variants
03/08/2007US20070054363 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders
03/08/2007US20070054361 Compositions and methods for the diagnosis and treatment of tumor
03/08/2007US20070054356 Glycine-rich proteins, their coding genes and applications
03/08/2007US20070054336 Compounds and methods for diagnosis and immunotherapy of tuberculosis
03/08/2007US20070054333 for identification on human chromosome 10 of a tumor suppressor gene;
03/08/2007US20070054332 Syndecan 1 ectodomain inhibits cancer
03/08/2007US20070054328 Methods
03/08/2007US20070054324 CAT1 transporters expressed in blood brain barrier cells
03/08/2007US20070054323 screening for therapeutic, cytotoxic or imaging compounds that can be transported through the blood brain barrier and used in the treatment or diagnosis of neurological diseases; organic cation transporter (OCT3)
03/08/2007US20070054320 Cytokine zalpha11 ligand antibodies
03/08/2007US20070054318 Soluble low-density lipoprotein receptor related protein binds directly to alzheimer's amyloid-beta peptide
03/08/2007US20070054312 Human transmembrane proteins
03/08/2007US20070054310 Novel polypeptide, cDNA encoding the same, and use thereof
03/08/2007US20070054307 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds
03/08/2007US20070054297 combining drugs with human orphan leucine-repeat-containing, G protein-coupled receptors (LGR7) polypeptides, then evaluating the level of binding to the hromones or the level of cAMP production; drug screening and design
03/08/2007US20070054290 Bind to hedgehog polypeptides with high affinity; exhibit spatially and temporally restricted expression domains indicative of important roles in hedgehog-mediated induction
03/08/2007US20070054284 Nucleic acid and corresponding protein entitled 184P1E2 useful in treatment and detection of cancer
03/08/2007US20070054271 Gene expression in breast cancer
03/08/2007US20070054001 Methods and compositions to enhance endogenous igf production and their uses
03/08/2007US20070053996 Light-activated cation channel and uses thereof
03/08/2007US20070053991 Cartilage-derived morphogenetic proteins
03/08/2007US20070053987 Cross-linked polysacharide and protein matrices and methods for their preparation
03/08/2007US20070053985 Coenzyme Q10-containing fine particle with excellent dispersibility
03/08/2007US20070053975 Ramipril formulation
03/08/2007US20070053970 Liposomal formulation for oral administration of glutathione (reduced) and/or methylcobalamine for diseases related to glutathione deficiency and deficiency of the methionine remethylation pathway
03/08/2007US20070053960 Multiribbon nanocellulose as a matrix for wound healing
03/08/2007US20070053938 Virulence of streptococci
03/08/2007US20070053928 Compounds useful in the diagnosis and treatment of pregnancy-associated malaria
03/08/2007US20070053926 Antigenic neisserial peptides
03/08/2007US20070053923 Dna vaccine composition with enhanced immunogenicity
03/08/2007US20070053922 Epitope based vaccines directed towards HPV; side effect reduction; vaccination
03/08/2007US20070053921 Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
03/08/2007US20070053918 Injectable depots consisting of liposomal aggregates for the delivery of active substances
03/08/2007US20070053916 Plasmodium falciparum peptide for use in stimulating immune response to treat and prevent malaria
03/08/2007US20070053915 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
03/08/2007US20070053911 Diagnostics and therapeutics for diseases associated with g-protein coupled proteinase activated receptor 2 (par2)
03/08/2007US20070053909 Method of treating fibrosis
03/08/2007US20070053908 Uses of human zven antagonists
03/08/2007US20070053907 Uses of human zven antagonists
03/08/2007US20070053906 Liquid formulations of tumor necrosis factor-binding proteins
03/08/2007US20070053904 Antibodies having diagnostic, preventive, therapeutic, and other uses
03/08/2007US20070053902 Anti-alphabeta3 humanized monoclonal antibodies
03/08/2007US20070053898 Method for reducing allergencity in indoor spaces
03/08/2007US20070053897 Calcium independent cytosolic phospholipase A2/B enzymes
03/08/2007US20070053896 Diagnostic marker for ovarian cancer
03/08/2007US20070053895 Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
03/08/2007US20070053894 Compound and method for regulating plasminogen activation and cell migration
03/08/2007US20070053893 Method of reducing immunological tolerance to malignancy
03/08/2007US20070053892 Methods and kits for co-administration of nutritional supplements
03/08/2007US20070053891 Snail, a new marker for tumour invasion and target protein of new antitumoral compounds
03/08/2007US20070053883 Neuronal cell lineages and methods of production thereof
03/08/2007US20070053880 Growth differentiation factor-16
03/08/2007US20070053878 Sars
1 ... 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 ... 3163